Radiofrequency ablation (RFA) is a catheter-based procedure that permanently eliminates abnormal electrical pathways or triggers driving arrhythmias. Instead of managing abnormal heart rhythms indefinitely with medications, ablation targets and destroys the small areas of tissue responsible for the abnormal electrical circuit, offering patients the possibility of a long-term cure rather than chronic symptom management.
RFA is the established treatment for a wide range of arrhythmias including SVT (supraventricular tachycardia), atrial flutter, and atrial fibrillation. It is performed in our Cath Lab under sedation or general anesthesia, typically takes 2 to 4 hours, and allows most patients to go home the following day. Success rates vary by arrhythmia type but are excellent for many common conditions treated at high-volume centers.
The heart's rhythm is controlled by electrical impulses that travel along specific pathways through the heart muscle. In arrhythmias, abnormal electrical circuits, accessory pathways, or ectopic foci (rogue firing points) generate disorganized impulses that override the normal rhythm.
In radiofrequency ablation, thin flexible catheters are advanced through veins in the groin to the inside of the heart. These catheters have sensors at their tips that both record electrical signals and deliver energy. Electroanatomical mapping systems build a three-dimensional map of the heart's electrical activity, identifying the precise location of the abnormal tissue responsible for the arrhythmia.
Once the target is identified, radiofrequency energy (a form of heat energy at controlled temperatures of 50 to 60 degrees Celsius) is delivered through the catheter tip to create a small scar (2 to 5mm in diameter) in the abnormal tissue. This scar does not conduct electricity, permanently interrupting the arrhythmia circuit. The surrounding healthy heart muscle is unaffected.
Pulmonary vein isolation (PVI) is the cornerstone of AFib ablation. The ablation catheter creates a ring of scar tissue around the pulmonary vein openings, isolating the electrical triggers that drive AFib from the rest of the atrium. Success rates for a single procedure in paroxysmal AFib are 70 to 80% at one year. Persistent AFib may require additional ablation beyond PVI.
Typical atrial flutter is caused by a predictable re-entry circuit in the right atrium involving the cavotricuspid isthmus (CTI). CTI ablation achieves cure rates above 95% in a single procedure and is one of the most successful ablation procedures performed.
SVT encompasses AVNRT (AV nodal re-entry tachycardia, the most common type), AVRT (involving an accessory pathway), and atrial tachycardia. Ablation achieves cure rates of 95 to 98% for AVNRT and over 90% for most other SVT subtypes in a single session.
An accessory electrical pathway connecting atria and ventricles causes SVT and, in some patients, risk of sudden cardiac arrest during AFib. Ablation of the accessory pathway is curative with success rates above 95%.
Ablation of VT circuits, usually arising from scar tissue after a heart attack or in cardiomyopathy, reduces VT burden and ICD shocks. VT ablation is technically the most demanding of all arrhythmia ablation procedures.
Frequent PVCs causing symptoms or reducing heart function can be ablated when a clear focal origin is identified on mapping. Success rates depend on PVC morphology and origin.
ECG, Holter monitoring, echocardiography, and blood tests. For AFib ablation, a CT or MRI of the left atrium and pulmonary veins is performed to map anatomy before the procedure. A transoesophageal echo (TOE) is performed on the day to rule out left atrial clot before transseptal puncture.
SVT and flutter ablations are typically performed under conscious sedation. AFib ablation is usually performed under general anesthesia or deep sedation due to the longer procedure duration and the need for the patient to remain completely still during pulmonary vein isolation.
Sheaths are inserted into the femoral veins in the groin (and occasionally the femoral artery for left-sided procedures). Three to four catheters are typically positioned in the heart simultaneously.
To access the left atrium for AFib ablation, a needle is used to cross the septum (the wall between the upper chambers) under ultrasound and X-ray guidance. This step requires technical precision.
Electrical recordings are taken from multiple points inside the heart. Three-dimensional mapping systems (such as CARTO or EnSite) build a real-time electroanatomical map of the arrhythmia circuit, guiding precise catheter positioning.
For SVT and flutter, the arrhythmia is deliberately induced with pacing techniques or medication to confirm the mechanism and locate the circuit. AFib ablation is performed anatomically based on the mapping system.
Energy is delivered at each target point for 30 to 60 seconds. Ablation is guided by temperature, impedance, and contact force feedback. Modern force-sensing catheters ensure consistent tissue contact and reduce risk of complications from excessive pressure.
For SVT and flutter, the arrhythmia should be non-inducible after ablation. For AFib, electrical silence within the pulmonary veins (exit and entrance block) confirms successful isolation. Further provocation testing ensures the arrhythmia cannot be reinduced.
All sheaths are removed and groin compression or vascular closure devices used to achieve hemostasis. The patient rests flat for 3 to 6 hours.
SVT and flutter ablations typically take 90 to 150 minutes. AFib ablation procedures take 2 to 4 hours. You are monitored closely throughout and the team pauses to update you on progress at key steps.
Over 95% cure rate in a single procedure.
95 to 98% cure rate in a single procedure.
Over 95% accessory pathway elimination.
70 to 80% freedom from AFib at 1 year. Repeat procedure increases success to 85 to 90%.
60 to 70% success with PVI plus additional substrate modification. Often requires more than one procedure.
75 to 85% success depending on PVC origin and operator experience.
1 to 2 days for most procedures.
Avoid strenuous activity for 48 to 72 hours to allow the venous puncture sites to heal.
Office work: 3 to 5 days. Physical work: 1 to 2 weeks.
48 to 72 hours after the procedure for most arrhythmias.
The first 3 months after AFib ablation are considered the blanking period. AFib recurrence during this time does not mean the procedure has failed, as inflammation and healing can temporarily cause arrhythmia. Antiarrhythmic drugs are often continued for 3 months.
Blood thinners are continued for at least 3 months after AFib ablation regardless of perceived success, and longer if stroke risk (CHA2DS2-VASc score) remains elevated.
Review at 3 months, 6 months, and 12 months. Holter monitoring to assess rhythm status.
Consult expert cardiologists in Hyderabad at Germanten Hospital
“Mr. MD Ibrahim Khan, 55 years old from Hyderabad, was admitted for Anterior Cruciate Ligament (ACL) surgery and was successfully treated at Germanten Hospital, Attapur by Dr. Mir Jawad Zar Khan, MS Orthopaedics, Joint Replacement Surgeon with 20 years of experience.”
“Mr. Abdul Ali, from Kenya, was suffering from knee pain. He visited Germanten Hospitals Hyderabad and was operated on by the top orthopaedist in Hyderabad, Dr. Mir Jawad Zar Khan. After the treatment, he is now able to lead a normal life. Before going back to his country, he shared his experience with the hospital.”
“Mr. Vishwanath Rao from Hyderabad approached Dr. Mir Jawad Zar Khan with severe knee pain. Dr. Jawad diagnosed his knee and suggested knee replacement surgery. After the surgery, Vishwanath Rao is now walking painlessly and without support. He and his family are grateful to Dr. Mir Jawad Zar Khan and Germanten Hospital.”
“Mr. Afeef from Hyderabad met with an accident, and his right-hand bone was fractured. He was taken to Germanten Hospital and treated by Dr. Mir Jawad Zar Khan, the best orthopedic surgeon in Hyderabad. After the surgery, he is now leading a normal life and is grateful to Dr. Jawad and the Germanten Hospital team.”
“Mr. Abdul Ali, 70 years old, was unable to walk due to osteoarthritis for 10 years. One of his nephews suggested Dr. Mir Jawad Zar Khan. He was diagnosed and suggested knee replacement surgery, which was successfully performed on 6th October 2019. Now, he walks without pain and support and is very grateful to Dr. Mir Jawad Zar Khan.”
“After pain in his hip made daily life difficult, Mr. Rabul Islam turned to the orthopedic expert at Germanten Hospital for help. Dr. Mir Jawad Zar Khan, MD of Germanten Hospital and Senior Orthopedic & Spine surgeon, performed total hip replacement surgery on Rabul Islam. Now he is enjoying life pain-free.”
Mr. Vishwanath Rao from Hyderabad, underwent Knee Replacement Surgery
Mr. MD Ibrahim Khan, 55 years old from Hyderabad, underwent ACL Surgery at Germanten Hospital.
Mr. Gulshan Kumar from Hyderabad, underwent Total Knee Replacement Surgery at Germanten Hospital.
Mrs. Deepika Rawat underwent ACL Reconstruction Surgery at Germanten Hospital.
Mr. Anil Ahuja, 65 years old from New Delhi, underwent Total Knee Replacement Surgery at Germanten Hospital.
Mr. Rabul Islam from Assam, underwent ACL Surgery at Germanten Hospital.
Mr. Abdul Ali, 70 years old from Dubai, underwent Knee Replacement Surgery at Germanten Hospital.
Mr. Afeef from Hyderabad, underwent Bone Fracture Surgery at Germanten Hospital.
Mr. Ibrahim, 25 years old from Dubai, underwent ACL Surgery at Germanten Hospital.
Mr. Abdul Ali, 20 years old from Kenya, underwent ACL Surgery at Germanten Hospital.
Connect with our experts doctors for guidance
Germanten Hospital is located in Attapur, one of South Hyderabad's most accessible neighborhoods. Patients from across southern and western Hyderabad can reach us within 20 to 30 minutes.